Literature DB >> 18708020

Rituximab (MabThera) therapy and safety management. Clinical tool guide.

Thao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, Philippe Goupille, Eric Hachulla, Charles Masson, Jacques Morel, Luc Mouthon, Alain Saraux, Thierry Schaeverbeke, Daniel Wendling, Xavier Mariette.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18708020     DOI： 10.1016/S1297-319X(08)73620-0

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN： 1297-319X            Impact factor:   4.929


× No keyword cloud information.
  12 in total

Review 1.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

Review 2.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

3.  Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.

Authors:  Mario Ojeda-Uribe; Naji Afif; Etienne Dahan; Laetitia Sparsa; Celine Haby; Jean Sibilia; David Ternant; Marc Ardizzone
Journal:  Clin Rheumatol       Date:  2013-01-05       Impact factor: 2.980

4.  CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis.

Authors:  Amina Bensalem; Denis Mulleman; Gilles Thibault; Nicolas Azzopardi; Philippe Goupille; Gilles Paintaud; David Ternant
Journal:  Br J Clin Pharmacol       Date:  2019-11-22       Impact factor: 4.335

5.  Antigenic burden and serum IgG concentrations influence rituximab pharmacokinetics in rheumatoid arthritis patients.

Authors:  Bertrand Lioger; Soujanya Ratna Edupuganti; Denis Mulleman; Christophe Passot; Céline Desvignes; Théodora Bejan-Angoulvant; Gilles Thibault; Valérie Gouilleux-Gruart; Julien Mélet; Gilles Paintaud; David Ternant
Journal:  Br J Clin Pharmacol       Date:  2017-04-12       Impact factor: 4.335

Review 6.  Comparison of national clinical practice guidelines and recommendations on vaccination of adult patients with autoimmune rheumatic diseases.

Authors:  Despoina Papadopoulou; Nikolaos V Sipsas
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

7.  Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab.

Authors:  Marion Heusele; Pierre Clerson; Benoit Guery; Marc Lambert; David Launay; Guillaume Lefevre; Sandrine Morell-Dubois; Hélène Maillard; Noémie Le Gouellec; Pierre-Yves Hatron; Eric Hachulla
Journal:  Clin Rheumatol       Date:  2014-02-02       Impact factor: 2.980

Review 8.  The Practice Guideline for Vaccinating Korean Patients with Autoimmune Inflammatory Rheumatic Disease.

Authors:  Yu Bin Seo; Su Jin Moon; Chan Hong Jeon; Joon Young Song; Yoon Kyoung Sung; Su Jin Jeong; Ki Tae Kwon; Eu Suk Kim; Jae Hoon Kim; Hyoun Ah Kim; Dong Jin Park; Sung Hoon Park; Jin Kyun Park; Joong Kyong Ahn; Ji Seon Oh; Jae Won Yun; Joo Hyun Lee; Hee Young Lee; Min Joo Choi; Won Suk Choi; Young Hwa Choi; Jung Hyun Choi; Jung Yeon Heo; Hee Jin Cheong; Shin Seok Lee
Journal:  Infect Chemother       Date:  2020-06

Review 9.  Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.

Authors:  Caterina Vacchi; Andreina Manfredi; Giulia Cassone; Gian Luca Erre; Carlo Salvarani; Marco Sebastiani
Journal:  Drugs Context       Date:  2021-01-15

10.  Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry.

Authors:  J H Salmon; P Cacoub; B Combe; J Sibilia; B Pallot-Prades; O Fain; A Cantagrel; M Dougados; E Andres; O Meyer; P Carli; E Pertuiset; I Pane; F Maurier; P Ravaud; X Mariette; J E Gottenberg
Journal:  RMD Open       Date:  2015-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.